SKINmed. 2013;11:85–91
Adele Sparavigna, MD;1 Michele Setaro, Eng;2 Maurizio Caserini, MD;3 Anna Bulgheroni, MSc3
The aim of this randomized, double-blind, controlled study was to evaluate the antidandruff activity exerted by a new shampoo on patients
affected by dandruff and/or mild seborrheic dermatitis by means of both D-squame technique coupled with image analysis and clinical assessments.
Thirty-four patients were enrolled and 1:1 randomly assigned to either a test shampoo or a comparative shampoo group. Treatment
schedule was twice a week for 4 weeks. The D-squame technique was shown to be able to objectively record variations in scalp desquamation
both between test and comparative groups and within the same group over time. The results obtained with this instrumental approach showed
a statistically significant reduction by 52% vs baseline after 2 weeks of treatment. There was an even greater reduction after 4 weeks (–66%).
This reduction was statistically significant compared with the comparative group at the same time points. The analysis of all the other parameters
(except Wood’s lamp) confirmed the superiority of the test vs the comparative shampoo. The test shampoo proved to be safe, well tolerated,
and accepted by the patients for cosmetic acceptability and efficacy. The study confirmed the antidandruff efficacy of the test shampoo
and its superiority vs the comparative shampoo.